Go back

Japan injects US$5m into parasitic disease drug research


Money should help develop treatment that breaks transmission cycles of elephantiasis and river blindness

Japan’s Global Health Innovative Technology Fund announced it is investing 790 million yen (US$5.3 million) into researching two neglected tropical diseases: lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness).

The funds will be used to develop new drugs for the diseases, which are caused by parasitic infection. “Even in the midst of a pandemic, GHIT Fund is committed to advancing product development to contribute to global health,” said Osamu Kunii, the fund’s CEO, in a statement on 11 November.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.